Replimune Group, Inc. (REPL)
8.07
+1.03
(+14.63%)
USD |
NASDAQ |
Mar 06, 16:00
9.21
+1.14
(+14.13%)
After-Hours: 20:00
Replimune Group SG&A Expense (TTM) : 103.07M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Sarepta Therapeutics, Inc. | 491.72M |
| REGENXBIO, Inc. | 60.48M |
| Bristol Myers Squibb Co. | 7.267B |
| Mirum Pharmaceuticals, Inc. | 257.03M |